PDGFRA and breast carcinoma: Raz et al. demonstrated that CAFs derived from bone marrow in breast cancer have low expression of PDGFRα and are functionally distinct from PDGFRα-expressing CAFs, which suggests that functional heterogeneity may, to some extent, be determined by the origin of CAFs [101].